Biodiversity Literature Repository

Submit to community
Liberated Data
Published May 31, 2020 | Version v1
Journal article Restricted

Lanostane triterpenoids with anti-inflammatory activities from Ganoderma lucidum

Authors/Creators

  • 1. ∗ & State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Science, Kunming, 650201, China & University of the Chinese Academy of Science, Beijing, 100049, China

Description

Su, Hai-Guo, Peng, Xing-Rong, Shi, Qiang-Qiang, Huang, Yan-Jie, Zhou, Lin, Qiu, Ming-Hua (2020): Lanostane triterpenoids with anti-inflammatory activities from Ganoderma lucidum. Phytochemistry (112256) 173: 1-7, DOI: 10.1016/j.phytochem.2019.112256, URL: http://dx.doi.org/10.1016/j.phytochem.2019.112256

Files

Restricted

The record is publicly accessible, but files are restricted. Log in to check if you have access.

Linked records

Additional details

Identifiers

LSID
urn:lsid:plazi.org:pub:6877633CFFF63E45FFF6FF946638B03E

Related works

Has part
Figure: 10.5281/zenodo.8294584 (DOI)
Figure: 10.5281/zenodo.8294586 (DOI)
Figure: 10.5281/zenodo.8294588 (DOI)
Figure: 10.5281/zenodo.8294590 (DOI)

References

  • Cheng, C.R., Yue, Q.X., Wu, Z.Y., Song, X.Y., Tao, S.J., Wu, X.H., Xu, P.P., Liu, X.A., Guan, S.H., Guo, D.A., 2010. Cytotoxic triterpenoids from Ganoderma lucidum. Phytochemistry 71, 1579-1585.
  • Dirsch, V.M., Stuppner, H., Vollmar, A.M., 1998. The Griess assay: suitable for a bioguided fractionation of anti-inflammatory plant extracts? Planta Med. 64, 423-426.
  • Donath, M.Y., Shoelson, S.E., 2011. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107.
  • Fatmawati, S., Shimizu, K., Kondo, R., 2011. Ganoderol B: a potent alpha-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Phytomedicine 18, 1053-1055.
  • Guan, S.H., Xia, J.M., Yang, M., Wang, X.M., Liu, X., Guo, D.A., 2008. Cytotoxic lanostanoid triterpenes from Ganoderma lucidum. J. Asian Nat. Prod. Res. 10, 695-700.
  • Hanahan, D., Weinberg, R.A., 2011. Hallmarks of cancer: the next generation. Cell 144, 646-674.
  • Huang, S.Z., Ma, Q.Y., Kong, F.D., Guo, Z.K., Cai, C.H., Hu, L.L., Zhou, L.M., Wang, Q., Dai, H.F., Mei, W.L., Zhao, Y.X., 2017. Lanostane-type triterpenoids from the fruiting body of Ganoderma calidophilum. Phytochemistry 143, 104-110.
  • Jang, H.J., Lee, S., Lee, S.J., Lim, H.J., Jung, K., Kim, Y.H., Lee, S.W., Rho, M.C., 2017. Anti-inflammatory activity of eudesmane-type sesquiterpenoids from Salvia plebeia. J. Nat. Prod. 80, 2666-2676.
  • Jiao, Y., Xie, T., Zou, L.H., Wei, Q., Qiu, L., Chen, L.X., 2016. Lanostane triterpenoids from Ganoderma curtisii and their NO production inhibitory activities of LPS-induced microglia. Bioorg. Med. Chem. Lett 26, 3556-3561.
  • Kikuchi, T., Matsuda, S., Kadota, S., Murai, Y., Ogita, Z., 1985a. Ganoderic acid D, E F and H and lucidenic acid-D, E, and F, new triterpenoids from Ganoderma lucidum. Chem. Pharm. Bull. 33, 2624-2627.
  • Kikuchi, T., Matsuda, S., Murai, Y., Ogita, Z., 1985b. Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum. Chem. Pharm. Bull. 33, 2628-2631.
  • Kohda, H., Tokumoto, W., Sakamoto, K., Fujii, M., Hirai, Y., Yamasaki, K., Komoda, Y., Nakamura, H., Ishihara, S., Uchida, M., 1985. The biologically active constituents of Ganoderma lucidum (Fr.) karst. histamine release inhibitory triterpenes. Chem. Pharm. Bull. 33, 1367-1374.
  • Kubota, T., Asaka, Y., Miura, I., Mori, H., 1982. Structures of ganoderic acid A and B, two new lanostane type bitter triterpenes from Ganoderma lucidum (Fr.) Karst. Helv. Chim. Acta 65, 611-619.
  • Liu, J.Q., Wang, C.F., Li, Y., Luo, H.R., Qiu, M.H., 2012. Isolation and bioactivity evaluation of terpenoids from the medicinal fungus Ganoderma sinense. Planta Med. 78, 368-376.
  • Nishitoba, T., Sato, H., Oda, K., Sakamura, S., 1988. Novel triterpenoids and a steroid from the fungus Ganoderma lucidum. Agric. Biol. Chem. 52, 211-216.
  • Nishitoba, T., Sato, H., Sakamura, S., 1985a. New terpenoids from Ganoderma lucidum and their bitterness. Agric. Biol. Chem. 49, 1547-1549.
  • Nishitoba, T., Sato, H., Sakamura, S., 1985b. New terpenoids, ganoderic acid J and ganolucidic acid C, from the fungus Ganoderma lucidum. Agric. Biol. Chem. 49, 3637-3638.
  • Peng, X.R., Liu, J.Q., Wang, C.F., Li, X.Y., Shu, Y., Zhou, L., Qiu, M.H., 2014. Hepatoprotective effects of triterpenoids from Ganoderma cochlear. J. Nat. Prod. 77, 737-743.
  • Peng, X., Li, L., Dong, J., Lu, S., Lu, J., Li, X., Zhou, L., Qiu, M., 2019. Lanostane-type triterpenoids from the fruiting bodies of Ganoderma applanatum. Phytochemistry 157, 103-110.
  • Peng, X., Li, L., Wang, X., Zhu, G., Li, Z., Qiu, M., 2016. Antioxidant farnesylated hydroquinones from Ganoderma capense. Fitoterapia 111, 18-23.
  • Peng, X., Liu, J., Wang, C., Han, Z., Shu, Y., Li, X., Zhou, L., Qiu, M., 2015a. Unusual prenylated phenols with antioxidant activities from Ganoderma cochlear. Food Chem. 171, 251-257.
  • Peng, X., Liu, J., Xia, J., Wang, C., Li, X., Deng, Y., Bao, N., Zhang, Z., Qiu, M., 2015b. Lanostane triterpenoids from Ganoderma hainanense. J. D. Zhao. Phytochem. 114, 137-145.
  • Saltiel, A.R., Olefsky, J.M., 2017. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Investig. 127, 1-4.
  • Sato, H., Nishitoba, T., Shirasu, S., Oda, K., Sakamura, S., 1986. Ganoderiol-A and ganoderiol-B, new triterpenoids from the fungus Ganoderma lucidum (Reishi). Agric. Biol. Chem. 50, 2887-2890.
  • Shim, S.H., Ryu, J., Kim, J.S., Kang, S.S., Xu, Y.N., Jung, S.H., Lee, Y.S., Lee, S., Shin, K.H., 2004. New lanostane-type triterpenoids from Ganoderma applanatum. J. Nat. Prod. 67, 1110-1113.
  • Su, H.G., Zhou, Q.M., Guo, L., Huang, Y.J., Peng, C., Xiong, L., 2018. Lanostane triterpenoids from Ganoderma luteomarginatum and their cytotoxicity against four human cancer cell lines. Phytochemistry 156, 89-95.
  • Wang, C.F., Liu, J.Q., Yan, Y.X., Chen, J.C., Lu, Y., Guo, Y.H., Qiu, M.H., 2010. Three new triterpenoids containing four-membered ring from the fruiting body of Ganoderma sinense. Org. Lett. 12, 1656-1659.
  • Wu, J.G., Kan, Y.J., Wu, Y.B., Yi, J., Chen, T.Q., Wu, J.Z., 2016. Hepatoprotective effect of ganoderma triterpenoids against oxidative damage induced by tert-butyl hydroperoxide in human hepatic HepG2 cells. Pharm. Biol. 54, 919-929.
  • Wu, Y.L., Han, F., Luan, S.S., Ai, R., Zhang, P., Li, H., Chen, L.X., 2019. Triterpenoids from Ganoderma lucidum and their potential anti-inflammatory effects. J. Agric. Food Chem. 67, 5147-5158.
  • Xia, Q., Zhang, H.Z., Sun, X.F., Zhao, H.J., Wu, L.F., Zhu, D., Yang, G.H., Shao, Y.Y., Zhang, X.X., Mao, X., Zhang, L.Z., She, G.M., 2014. A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp. Molecules 19, 17478-17535.
  • Zhao, X.R., Huo, X.K., Dong, P.P., Wang, C., Huang, S.S., Zhang, B.J., Zhang, H.L., Deng, S., Liu, K.X., Ma, X.C., 2015. Inhibitory effects of highly oxygenated lanostane derivatives from the fungus Ganoderma lucidum on P-glycoprotein and alpha-glucosidase. J. Nat. Prod. 78, 1868-1876.